Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Operating Expenses | 57,278 | 1,536 | 1,777 | 1,991 | 1,812 |
| Operating Income | -57,278 | -1,536 | -1,777 | -1,991 | -1,812 |
| Interest Expense | 564 | 666 | 533 | 569 | 450 |
| Other Income | -1,081 | 252 | -481 | -153 | 122 |
| Pre-tax Income | -58,923 | -1,950 | -2,790 | -2,713 | -2,139 |
| Income Tax | N/A | -129 | -130 | -55 | -113 |
| Net Income Continuous | -58,923 | -1,821 | -2,661 | -2,658 | -2,026 |
| Net Income | $-58,923 | $-1,821 | $-2,661 | $-2,658 | $-2,026 |
| EPS Basic Total Ops | -14.85 | -1,420.53 | -112,500.00 | -3,076,875.00 | -0.80 |
| EPS Basic Continuous Ops | -14.85 | -1,284.78 | -95,621.26 | -2,435,252.00 | -0.67 |
| EPS Diluted Total Ops | -14.85 | -1,420.53 | -112,500.00 | -3,076,875.00 | -0.80 |
| EPS Diluted Continuous Ops | -14.85 | -1,284.78 | -95,621.26 | -2,435,252.00 | -0.67 |
| EPS Diluted Before Non-Recurring Items | -14.85 | -1,250.00 | -112,500.00 | N/A | N/A |
| EBITDA(a) | $-57,278 | $-1,536 | $-1,775 | $-1,989 | $-1,810 |